These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18788393)

  • 1. [Molecular pathogenesis of chronic kidney disease].
    Kashihara N; Satoh M
    Nihon Rinsho; 2008 Sep; 66(9):1671-7. PubMed ID: 18788393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathogenesis of cardiorenal disease.
    Keane WF
    Am J Kidney Dis; 2001 Dec; 38(6):1372-5. PubMed ID: 11728977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.
    Dell'Omo G; Penno G; Pucci L; Fotino C; Lucchesi D; Del Prato S; Pedrinelli R
    J Hypertens; 2007 Jul; 25(7):1389-95. PubMed ID: 17563560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
    Heo NJ; Ahn JM; Lee TW; Chin HJ; Na KY; Chae DW; Kim S
    Hypertens Res; 2010 Jun; 33(6):573-8. PubMed ID: 20379188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormalities in renal hemodynamics].
    Ueda H; Ishimura E
    Nihon Rinsho; 2008 Sep; 66(9):1689-95. PubMed ID: 18788395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart and kidney: fatal twins?
    Ritz E
    Am J Med; 2006 May; 119(5 Suppl 1):S31-9. PubMed ID: 16563946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to abandon microalbuminuria?
    Ruggenenti P; Remuzzi G
    Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T; Gejyo F
    Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?
    Schmieder RE
    J Hypertens Suppl; 2006 Apr; 24(2):S31-5. PubMed ID: 16601559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of proteinuria: CKD progression and cardiovascular outcomes.
    Sarnak MJ; Astor BC
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):258-66. PubMed ID: 21782132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.